US2779780A
(en)
|
1955-03-01 |
1957-01-29 |
Du Pont |
1, 4-diamino-2, 3-dicyano-1, 4-bis (substituted mercapto) butadienes and their preparation
|
GB8827305D0
(en)
|
1988-11-23 |
1988-12-29 |
British Bio Technology |
Compounds
|
US5587458A
(en)
|
1991-10-07 |
1996-12-24 |
Aronex Pharmaceuticals, Inc. |
Anti-erbB-2 antibodies, combinations thereof, and therapeutic and diagnostic uses thereof
|
EP1997894B1
(en)
|
1992-02-06 |
2011-03-30 |
Novartis Vaccines and Diagnostics, Inc. |
Biosynthetic binding protein for cancer marker
|
US6177401B1
(en)
|
1992-11-13 |
2001-01-23 |
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften |
Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis
|
US5455258A
(en)
|
1993-01-06 |
1995-10-03 |
Ciba-Geigy Corporation |
Arylsulfonamido-substituted hydroxamic acids
|
EP0647450A1
(en)
|
1993-09-09 |
1995-04-12 |
BEHRINGWERKE Aktiengesellschaft |
Improved prodrugs for enzyme mediated activation
|
IL112248A0
(en)
|
1994-01-25 |
1995-03-30 |
Warner Lambert Co |
Tricyclic heteroaromatic compounds and pharmaceutical compositions containing them
|
US5521173A
(en)
|
1995-01-17 |
1996-05-28 |
American Home Products Corporation |
Tricyclic benzazepine vasopressin antagonists
|
US5863949A
(en)
|
1995-03-08 |
1999-01-26 |
Pfizer Inc |
Arylsulfonylamino hydroxamic acid derivatives
|
PT821671E
(pt)
|
1995-04-20 |
2001-04-30 |
Pfizer |
Derivados do acido arilsulfonil hidroxamico como inibidores de mmp e tnf
|
GB9508538D0
(en)
|
1995-04-27 |
1995-06-14 |
Zeneca Ltd |
Quinazoline derivatives
|
US5747498A
(en)
|
1996-05-28 |
1998-05-05 |
Pfizer Inc. |
Alkynyl and azido-substituted 4-anilinoquinazolines
|
US5880141A
(en)
|
1995-06-07 |
1999-03-09 |
Sugen, Inc. |
Benzylidene-Z-indoline compounds for the treatment of disease
|
GB9520822D0
(en)
|
1995-10-11 |
1995-12-13 |
Wellcome Found |
Therapeutically active compounds
|
GB9523675D0
(en)
*
|
1995-11-20 |
1996-01-24 |
Celltech Therapeutics Ltd |
Chemical compounds
|
GB9624482D0
(en)
|
1995-12-18 |
1997-01-15 |
Zeneca Phaema S A |
Chemical compounds
|
DE69624081T2
(de)
|
1995-12-20 |
2003-06-12 |
Hoffmann La Roche |
Matrix-metalloprotease Inhibitoren
|
AU1618697A
(en)
|
1996-02-06 |
1997-08-28 |
Japan Tobacco Inc. |
Novel compounds and pharmaceutical use thereof
|
PT885198E
(pt)
|
1996-03-05 |
2002-06-28 |
Astrazeneca Ab |
Derivados de 4-anilinoquinazolina
|
JP3195756B2
(ja)
|
1996-07-04 |
2001-08-06 |
公子 吉水 |
潤滑補助体
|
EP0818442A3
(en)
|
1996-07-12 |
1998-12-30 |
Pfizer Inc. |
Cyclic sulphone derivatives as inhibitors of metalloproteinases and of the production of tumour necrosis factor
|
CN1230185A
(zh)
|
1996-07-13 |
1999-09-29 |
葛兰素集团有限公司 |
双环芳杂环化合物用作蛋白质酪氨酸激酶的抑制剂
|
PT912559E
(pt)
|
1996-07-13 |
2003-03-31 |
Glaxo Group Ltd |
Compostos heterociclicos fundidos como inibidores de proteina tirosina quinase
|
HRP970371A2
(en)
|
1996-07-13 |
1998-08-31 |
Kathryn Jane Smith |
Heterocyclic compounds
|
WO1998003516A1
(en)
|
1996-07-18 |
1998-01-29 |
Pfizer Inc. |
Phosphinate based inhibitors of matrix metalloproteases
|
IL128189A0
(en)
|
1996-08-23 |
1999-11-30 |
Pfizer |
Arylsulfonylamino hydroxamic acid derivatives
|
ID18494A
(id)
|
1996-10-02 |
1998-04-16 |
Novartis Ag |
Turunan pirazola leburan dan proses pembuatannya
|
DZ2376A1
(fr)
|
1996-12-19 |
2002-12-28 |
Smithkline Beecham Plc |
Dérivés de sulfonamides nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant.
|
EP0950059B1
(en)
|
1997-01-06 |
2004-08-04 |
Pfizer Inc. |
Cyclic sulfone derivatives
|
ES2202796T3
(es)
|
1997-02-03 |
2004-04-01 |
Pfizer Products Inc. |
Derivados de acidos arilsulfonilaminohidroxamicos.
|
EP0966438A1
(en)
|
1997-02-07 |
1999-12-29 |
Pfizer Inc. |
N-hydroxy-beta-sulfonyl-propionamide derivatives and their use as inhibitors of matrix metalloproteinases
|
JP3710489B2
(ja)
|
1997-02-11 |
2005-10-26 |
ファイザー・インク |
アリールスルホニルヒドロキサム酸誘導体
|
CA2289102A1
(en)
|
1997-05-07 |
1998-11-12 |
Sugen, Inc. |
2-indolinone derivatives as modulators of protein kinase activity
|
AU734009B2
(en)
|
1997-05-30 |
2001-05-31 |
Merck & Co., Inc. |
Novel angiogenesis inhibitors
|
US5835420A
(en)
|
1997-06-27 |
1998-11-10 |
Aplus Flash Technology, Inc. |
Node-precise voltage regulation for a MOS memory system
|
UA61963C2
(en)
|
1997-08-08 |
2003-12-15 |
Pfizer Prod Inc |
Aryloxysulfonylaminohydroxamic acid derivatives
|
ES2289791T3
(es)
|
1997-08-22 |
2008-02-01 |
Astrazeneca Ab |
Derivados de oxindolilquinazolina como inhibidores de la angiogenesis.
|
JP2001518470A
(ja)
|
1997-09-26 |
2001-10-16 |
メルク エンド カムパニー インコーポレーテッド |
新規な血管形成阻害剤
|
CA2309690A1
(en)
|
1997-11-11 |
1999-05-20 |
Pfizer Products Inc. |
Thienopyrimidine and thienopyridine derivatives useful as anticancer agents
|
GB9725782D0
(en)
|
1997-12-05 |
1998-02-04 |
Pfizer Ltd |
Therapeutic agents
|
GB9800569D0
(en)
|
1998-01-12 |
1998-03-11 |
Glaxo Group Ltd |
Heterocyclic compounds
|
GB9800575D0
(en)
|
1998-01-12 |
1998-03-11 |
Glaxo Group Ltd |
Heterocyclic compounds
|
GB9801690D0
(en)
|
1998-01-27 |
1998-03-25 |
Pfizer Ltd |
Therapeutic agents
|
GB2335781A
(en)
|
1998-03-24 |
1999-09-29 |
Soho Soundhouse Limited |
Method of selection of audio samples
|
JP4462654B2
(ja)
|
1998-03-26 |
2010-05-12 |
ソニー株式会社 |
映像素材選択装置及び映像素材選択方法
|
PA8469501A1
(es)
|
1998-04-10 |
2000-09-29 |
Pfizer Prod Inc |
Hidroxamidas del acido (4-arilsulfonilamino)-tetrahidropiran-4-carboxilico
|
PA8469401A1
(es)
|
1998-04-10 |
2000-05-24 |
Pfizer Prod Inc |
Derivados biciclicos del acido hidroxamico
|
EA005032B1
(ru)
|
1998-05-29 |
2004-10-28 |
Сьюджен, Инк. |
Пирролзамещенные 2-индолиноны (варианты), фармацевтическая композиция (варианты), способ модулирования каталитической активности протеинкиназы, способ лечения или профилактики нарушения в организме, связанного с протеинкиназой
|
UA60365C2
(uk)
|
1998-06-04 |
2003-10-15 |
Пфайзер Продактс Інк. |
Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця
|
US6114361A
(en)
|
1998-11-05 |
2000-09-05 |
Pfizer Inc. |
5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives
|
WO2000035436A2
(en)
|
1998-12-16 |
2000-06-22 |
Warner-Lambert Company |
Treatment of arthritis with mek inhibitors
|
UA71945C2
(en)
|
1999-01-27 |
2005-01-17 |
Pfizer Prod Inc |
Substituted bicyclic derivatives being used as anticancer agents
|
ES2243228T3
(es)
|
1999-02-11 |
2005-12-01 |
Pfizer Products Inc. |
Derivados quinolin-2-ona sustituidos con heteroarilo utiles como agentes anticancerigenos.
|
US6511993B1
(en)
|
1999-06-03 |
2003-01-28 |
Kevin Neil Dack |
Metalloprotease inhibitors
|
CA2277654A1
(en)
*
|
1999-07-19 |
2001-01-19 |
Luxell Technologies Inc. |
Electroluminescent display packaging and method therefor
|
EP1081137A1
(en)
|
1999-08-12 |
2001-03-07 |
Pfizer Products Inc. |
Selective inhibitors of aggrecanase in osteoarthritis treatment
|
GB9924862D0
(en)
|
1999-10-20 |
1999-12-22 |
Celltech Therapeutics Ltd |
Chemical compounds
|
ES2290117T3
(es)
|
2000-02-15 |
2008-02-16 |
Sugen, Inc. |
Inhibidores de proteina quinasa 2-indolina sustituida con pirrol.
|
CN1429222A
(zh)
|
2000-02-17 |
2003-07-09 |
安姆根有限公司 |
激酶抑制剂
|
US6440207B1
(en)
|
2000-03-03 |
2002-08-27 |
Bayer Corporation |
Method for preparing organic pigments
|
US7163921B1
(en)
|
2000-04-14 |
2007-01-16 |
Nippon Shinyaku Co., Ltd. |
Peptide derivatives and medicinal compositions
|
AU5889701A
(en)
|
2000-06-05 |
2001-12-17 |
Dong A Pharm Co Ltd |
Novel oxazolidinone derivatives and a process for the preparation thereof
|
PL203387B1
(pl)
|
2000-07-19 |
2009-09-30 |
Warner Lambert Co |
Utlenione estry kwasu 4-jodofenyloaminobenzhydroksamowego
|
US6995162B2
(en)
|
2001-01-12 |
2006-02-07 |
Amgen Inc. |
Substituted alkylamine derivatives and methods of use
|
WO2002094766A1
(fr)
|
2001-05-18 |
2002-11-28 |
Nihon Nohyaku Co., Ltd. |
Derive de phtalamide, insecticide agricole et horticole et son utilisation
|
WO2003003009A1
(en)
|
2001-06-29 |
2003-01-09 |
7Tm Pharma A/S |
Use of metal-ion chelates in validating biological molecules as drug targets in test animal models
|
US6939874B2
(en)
|
2001-08-22 |
2005-09-06 |
Amgen Inc. |
Substituted pyrimidinyl derivatives and methods of use
|
WO2003035065A1
(en)
|
2001-10-26 |
2003-05-01 |
Aventis Pharmaceuticals Inc |
Benzimidazoles and analogues and their use as protein kinases inhibitors
|
US6897208B2
(en)
|
2001-10-26 |
2005-05-24 |
Aventis Pharmaceuticals Inc. |
Benzimidazoles
|
WO2003055477A1
(en)
|
2001-12-21 |
2003-07-10 |
7Tm Pharma A/S |
Method for the treatment of mc receptor related disorders with a chelate and/or a chelator
|
RU2343148C2
(ru)
*
|
2002-02-01 |
2009-01-10 |
Райджел Фармасьютикалз, Инк |
Соединения 2,4-пиримидиндиаминов и их применение
|
TWI329105B
(en)
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
NZ535101A
(en)
|
2002-03-08 |
2007-07-27 |
Eisai Co Ltd |
Macrocyclic compounds useful as pharmaceuticals
|
AR038971A1
(es)
|
2002-03-13 |
2005-02-02 |
Array Biopharma Inc |
Derivados de bencimidazol n3 alquilado como inhibidores de mek
|
GB0206215D0
(en)
|
2002-03-15 |
2002-05-01 |
Novartis Ag |
Organic compounds
|
GB0206860D0
(en)
|
2002-03-22 |
2002-05-01 |
Glaxo Group Ltd |
Compounds
|
JP4171702B2
(ja)
|
2002-03-25 |
2008-10-29 |
日本化薬株式会社 |
新規α−アミノ−N−(ジアミノホスフィニル)ラクタム誘導体
|
AR039241A1
(es)
|
2002-04-04 |
2005-02-16 |
Biogen Inc |
Heteroarilos trisustituidos y metodos para su produccion y uso de los mismos
|
AU2003231231A1
(en)
|
2002-05-06 |
2003-11-11 |
Bayer Pharmaceuticals Corporation |
Pyridinyl amino pyrimidine derivatives useful for treating hyper-proliferative disorders
|
KR100588457B1
(ko)
|
2002-08-09 |
2006-06-12 |
다이쇼 세이야꾸 가부시끼가이샤 |
아릴 5-티오-β-D-글루코피라노시드 유도체 및 이를함유하는 당뇨병 치료약
|
UA80295C2
(en)
|
2002-09-06 |
2007-09-10 |
Biogen Inc |
Pyrazolopyridines and using the same
|
JP4608852B2
(ja)
|
2002-10-15 |
2011-01-12 |
チッソ株式会社 |
液晶性ビニルケトン誘導体およびその重合体
|
AU2003287878A1
(en)
|
2002-12-11 |
2004-06-30 |
7Tm Pharma A/S |
Quinoline compounds for use in mch receptor related disorders
|
ES2325440T3
(es)
|
2003-02-20 |
2009-09-04 |
Smithkline Beecham Corporation |
Compuestos de pirimidina.
|
BRPI0300660B8
(pt)
|
2003-02-28 |
2021-07-27 |
Fapesp Fund De Amparo A Pesquisa Do Estado De Sao Paulo |
método para quantificar liberação mitocondrial de citocromo c e kit para detectar liberação mitocondrial de citocromo c
|
GB0319227D0
(en)
*
|
2003-08-15 |
2003-09-17 |
Novartis Ag |
Organic compounds
|
GB0305929D0
(en)
|
2003-03-14 |
2003-04-23 |
Novartis Ag |
Organic compounds
|
US20040242655A1
(en)
|
2003-05-28 |
2004-12-02 |
Anziano Paul Q. |
Compositions and methods for inhibiting an isoform of human manganese superoxide dismutase
|
US20050070554A1
(en)
*
|
2003-08-27 |
2005-03-31 |
Amgen Inc. |
Substituted heterocyclic compounds and methods of use
|
JP2007505858A
(ja)
*
|
2003-09-18 |
2007-03-15 |
ノバルティス アクチエンゲゼルシャフト |
増殖性障害の処置に有用な2,4−ジ(フェニルアミノ)ピリミジン
|
WO2005082892A2
(en)
|
2004-02-17 |
2005-09-09 |
Dr. Reddy's Laboratories Ltd. |
Triazole compounds as antibacterial agents and pharmaceutical compositions containing them
|
JP2007532558A
(ja)
|
2004-04-09 |
2007-11-15 |
メルク エンド カムパニー インコーポレーテッド |
Akt活性の阻害剤
|
JP2008511631A
(ja)
|
2004-08-31 |
2008-04-17 |
バイオジェン・アイデック・エムエイ・インコーポレイテッド |
TGF−βインヒビターとしてのピリミジニルイミダゾール
|
US7786153B2
(en)
|
2005-03-02 |
2010-08-31 |
Abbott Laboratories Inc. |
Compounds that are useful for improving pharmacokinetics
|
WO2007027238A2
(en)
|
2005-05-03 |
2007-03-08 |
Rigel Pharmaceuticals, Inc. |
Jak kinase inhibitors and their uses
|
WO2006124874A2
(en)
|
2005-05-12 |
2006-11-23 |
Kalypsys, Inc. |
Inhibitors of b-raf kinase
|
EP2295496A1
(en)
|
2005-06-29 |
2011-03-16 |
Saint-Gobain Abrasives, Inc. |
High performance resin for abrasive products
|
US20070032514A1
(en)
|
2005-07-01 |
2007-02-08 |
Zahn Stephan K |
2,4-diamino-pyrimidines as aurora inhibitors
|
WO2007014011A2
(en)
|
2005-07-21 |
2007-02-01 |
Ardea Biosciences, Inc. |
N-(arylamino)-sulfonamide inhibitors of mek
|
US8604042B2
(en)
|
2005-11-01 |
2013-12-10 |
Targegen, Inc. |
Bi-aryl meta-pyrimidine inhibitors of kinases
|
KR101467723B1
(ko)
|
2005-11-01 |
2014-12-03 |
탈자진 인코포레이티드 |
키나제의 비-아릴 메타-피리미딘 억제제
|
US8133900B2
(en)
|
2005-11-01 |
2012-03-13 |
Targegen, Inc. |
Use of bi-aryl meta-pyrimidine inhibitors of kinases
|
ZA200804083B
(en)
*
|
2005-11-01 |
2009-09-30 |
Targegen Inc |
Bi-aryl meta-pyrimidine inhibitors of kinases
|
AU2006336506B2
(en)
|
2006-01-13 |
2012-06-28 |
Pharmacyclics Llc |
Inhibitors of tyrosine kinases and uses thereof
|
JO2660B1
(en)
|
2006-01-20 |
2012-06-17 |
نوفارتيس ايه جي |
Pi-3 inhibitors and methods of use
|
KR20080110998A
(ko)
|
2006-01-30 |
2008-12-22 |
엑셀리시스, 인코포레이티드 |
Jak2 조절자로서 4아릴2아미노피리미딘 또는 4아릴2아미노알킬피리미딘 및 이들을 포함하는 약제학적 조성물
|
CN101421250A
(zh)
*
|
2006-01-30 |
2009-04-29 |
埃克塞里艾克西斯公司 |
作为jak-2调节剂的4-芳基-2-氨基-嘧啶或4-芳基-2-氨基烷基-嘧啶及包含它们的药物组合物
|
JP2009528295A
(ja)
|
2006-02-24 |
2009-08-06 |
ライジェル ファーマシューティカルズ, インコーポレイテッド |
Jak経路の阻害のための組成物および方法
|
US8263772B2
(en)
|
2006-06-08 |
2012-09-11 |
Eli Lilly And Company |
MCH receptor antagonists
|
EP2054392A2
(en)
|
2006-06-15 |
2009-05-06 |
Boehringer Ingelheim International GmbH |
2-anilino-4-(heterocyclic)amino-pyrimidines as inhibitors of protein kinase c-alpha
|
HUE028086T2
(hu)
|
2006-09-22 |
2016-11-28 |
Pharmacyclics Llc |
Bruton tirozin-kináz gátlók
|
MX2009004426A
(es)
|
2006-10-23 |
2009-08-12 |
Cephalon Inc |
Derivados biciclicos fusionados de 2,4-diaminopirimidina como inhibidores alk y c-met.
|
US8987233B2
(en)
|
2006-11-03 |
2015-03-24 |
Pharmacyclics, Inc. |
Bruton's tyrosine kinase activity probe and method of using
|
TW200902010A
(en)
|
2007-01-26 |
2009-01-16 |
Smithkline Beecham Corp |
Anthranilamide inhibitors of aurora kinase
|
EP2114900B1
(en)
|
2007-01-31 |
2018-10-10 |
YM BioSciences Australia Pty Ltd |
Thiopyrimidine-based compounds and uses thereof
|
KR20090129434A
(ko)
|
2007-03-01 |
2009-12-16 |
수퍼젠, 인크. |
피리미딘-2,4-디아민 유도체 및 jak2 키나제 억제제로서의 이의 용도
|
CN101657431A
(zh)
|
2007-03-01 |
2010-02-24 |
休普基因公司 |
嘧啶-2,4-二胺衍生物及其作为jak2激酶抑制剂的用途
|
US7947698B2
(en)
*
|
2007-03-23 |
2011-05-24 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the JAK pathway
|
WO2008118823A2
(en)
|
2007-03-26 |
2008-10-02 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the jak pathway
|
US20120101114A1
(en)
|
2007-03-28 |
2012-04-26 |
Pharmacyclics, Inc. |
Inhibitors of bruton's tyrosine kinase
|
WO2008124085A2
(en)
|
2007-04-03 |
2008-10-16 |
Exelixis, Inc. |
Methods of using combinations of mek and jak-2 inhibitors
|
CA2682733A1
(en)
|
2007-04-13 |
2008-10-23 |
Supergen, Inc. |
Axl kinase inhibitors
|
CA2686378C
(en)
|
2007-05-04 |
2012-07-24 |
Irm Llc |
Pyrimidine derivatives and compositions as c-kit and pdgfr kinase inhibitors
|
WO2009010794A1
(en)
|
2007-07-19 |
2009-01-22 |
Astrazeneca Ab |
2,4-diamino-pyrimidine derivatives
|
MX338504B
(es)
|
2007-09-12 |
2016-04-20 |
Genentech Inc |
Combinaciones de compuestos inhibidores de fosfoinosituro 3-cinasa y agentes quimioterapeuticos, y metodos de uso.
|
JP5348725B2
(ja)
|
2007-10-25 |
2013-11-20 |
ジェネンテック, インコーポレイテッド |
チエノピリミジン化合物の製造方法
|
CA2710118A1
(en)
|
2007-12-20 |
2009-07-02 |
Cellzome Limited |
Sulfamides as zap-70 inhibitors
|
AU2009248923B2
(en)
*
|
2008-05-21 |
2015-01-29 |
Takeda Pharmaceutical Company Limited |
Phosphorous derivatives as kinase inhibitors
|
MX2010014568A
(es)
*
|
2008-06-25 |
2011-03-29 |
Irm Llc |
Derivados de pirmidina como inhibidores de cinasa.
|
US8338439B2
(en)
|
2008-06-27 |
2012-12-25 |
Celgene Avilomics Research, Inc. |
2,4-disubstituted pyrimidines useful as kinase inhibitors
|
RU2536584C2
(ru)
*
|
2008-06-27 |
2014-12-27 |
Авила Терапьютикс, Инк. |
Гетероарильные соединения и их применение
|
WO2010009342A2
(en)
|
2008-07-16 |
2010-01-21 |
Pharmacyclics, Inc. |
Inhibitors of bruton's tyrosine kinase for the treatment of solid tumors
|
JP2011528338A
(ja)
|
2008-07-18 |
2011-11-17 |
サノフイ−アベンテイス |
新規イミダゾ[1,2−a]ピリジン誘導体、この調製方法、この医薬としての使用、医薬組成物、および新規用途、特にMET阻害剤としての用途
|
US20100029675A1
(en)
|
2008-07-25 |
2010-02-04 |
Hwang Soo-In |
Pyrimidine-2, 4-diamine JAK2 Kinase inhibiting anti-inflammation use
|
WO2010017122A2
(en)
|
2008-08-05 |
2010-02-11 |
Targegen Inc. |
Methods of treating thalassemia
|
PT2389372E
(pt)
|
2009-01-23 |
2016-01-07 |
Rigel Pharmaceuticals Inc |
Composições e métodos para a inibição da via jak
|
WO2010090764A1
(en)
|
2009-02-09 |
2010-08-12 |
Supergen, Inc. |
Pyrrolopyrimidinyl axl kinase inhibitors
|
WO2010118986A1
(en)
|
2009-04-14 |
2010-10-21 |
Cellzome Limited |
Fluoro substituted pyrimidine compounds as jak3 inhibitors
|
WO2011031896A2
(en)
|
2009-09-09 |
2011-03-17 |
Avila Therapeutics, Inc. |
Pi3 kinase inhibitors and uses thereof
|
US9556426B2
(en)
|
2009-09-16 |
2017-01-31 |
Celgene Avilomics Research, Inc. |
Protein kinase conjugates and inhibitors
|
US7718662B1
(en)
|
2009-10-12 |
2010-05-18 |
Pharmacyclics, Inc. |
Pyrazolo-pyrimidine inhibitors of bruton's tyrosine kinase
|
AU2010306927A1
(en)
|
2009-10-12 |
2012-05-31 |
Myrexis, Inc. |
Amino - pyrimidine compounds as inhibitors of TBKL and/or IKK epsilon
|
AU2011211306B2
(en)
|
2010-01-29 |
2016-07-07 |
Otsuka Pharmaceutical Co., Ltd. |
Di - substituted pyridine derivatives as anticancers
|
WO2011106168A1
(en)
|
2010-02-24 |
2011-09-01 |
Dcam Pharma Inc |
Purine compounds for treating autoimmune and demyelinating diseases
|
TW201202242A
(en)
|
2010-03-30 |
2012-01-16 |
Sanofi Aventis |
6-(alkyl-or cycloalkyl-triazolopyridazine-sulfanyl)benzo-thiazole derivatives: preparation, and use as medicaments and as MET inhibitors
|
CA2800913C
(en)
|
2010-06-03 |
2019-07-23 |
Pharmacyclics, Inc. |
The use of inhibitors of bruton's tyrosine kinase (btk)
|
CA2794731C
(en)
|
2010-06-18 |
2019-03-19 |
Genentech, Inc. |
Anti-axl antibodies and methods of use
|
WO2012135641A2
(en)
|
2011-03-30 |
2012-10-04 |
H. Lee Moffitt Cancer Center And Research Institute |
Aurora kinase inhibitors and methods of making and using thereof
|
EP2693881B1
(en)
|
2011-04-01 |
2019-09-04 |
University of Utah Research Foundation |
Substituted n-phenylpyrimidin-2-amine analogs as inhibitors of the axl kinase
|
WO2012135801A1
(en)
|
2011-04-01 |
2012-10-04 |
University Of Utah Research Foundation |
Substituted n-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase btk inhibitors
|
CN104080454B
(zh)
|
2011-06-06 |
2017-02-15 |
爱荷华大学研究基金会 |
用于抑制肌萎缩的方法
|
WO2013010136A2
(en)
|
2011-07-13 |
2013-01-17 |
Pharmacyclics, Inc. |
Inhibitors of bruton's tyrosine kinase
|
JP6506555B2
(ja)
|
2011-10-19 |
2019-04-24 |
ファーマサイクリックス エルエルシー |
ブルトン型チロシンキナーゼ(Btk)阻害剤の使用
|
CN103087077B
(zh)
|
2011-11-03 |
2016-05-18 |
上海希迈医药科技有限公司 |
噻吩并嘧啶和呋喃并嘧啶类衍生物、其制备方法及其在医药上的应用
|
US8377946B1
(en)
|
2011-12-30 |
2013-02-19 |
Pharmacyclics, Inc. |
Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors
|
US8501724B1
(en)
|
2012-01-31 |
2013-08-06 |
Pharmacyclics, Inc. |
Purinone compounds as kinase inhibitors
|
WO2013173518A1
(en)
|
2012-05-16 |
2013-11-21 |
Pharmacyclics, Inc. |
Inhibitors of bruton's tyrosine kinase
|
CN110354132A
(zh)
|
2012-06-04 |
2019-10-22 |
药品循环有限责任公司 |
布鲁顿酪氨酸激酶抑制剂的晶形
|
EP2877598A1
(en)
|
2012-07-24 |
2015-06-03 |
Pharmacyclics, Inc. |
Mutations associated with resistance to inhibitors of bruton's tyrosine kinase (btk)
|
US8703981B2
(en)
|
2012-08-03 |
2014-04-22 |
Xerox Corporation |
Lignosulfonate compounds for solid ink applications
|
ES2618007T3
(es)
*
|
2012-08-06 |
2017-06-20 |
Acea Biosciences, Inc. |
Nuevos compuestos de pirrolopirimidina como inhibidores de proteína cinasas
|
KR101446742B1
(ko)
*
|
2012-08-10 |
2014-10-01 |
한국화학연구원 |
N2,n4-비스(4-(피페라진-1-일)페닐)피리미딘-2,4-디아민 유도체 또는 이의 약학적으로 허용가능한 염 및 이를 유효성분으로 함유하는 암의 예방 또는 치료용 약학적 조성물
|
CA2886275A1
(en)
|
2012-09-26 |
2014-04-03 |
Mannkind Corporation |
Multiple kinase pathway inhibitors
|
BR112015011171A2
(pt)
|
2012-11-15 |
2017-07-11 |
Pharmacyclics Inc |
compostos de pirrolopirimidina como inibidores da quinase
|
ES2805359T3
(es)
*
|
2013-02-08 |
2021-02-11 |
Celgene Car Llc |
Inhibidores de ERK y sus usos
|
WO2014130411A1
(en)
*
|
2013-02-22 |
2014-08-28 |
Emory University |
Tgf-beta enhancing compositions for cartilage repair and methods related thereto
|
US9708326B2
(en)
|
2013-02-25 |
2017-07-18 |
Pharmacyclics Llc |
Inhibitors of bruton's tyrosine kinase
|
JP2016510745A
(ja)
|
2013-03-04 |
2016-04-11 |
ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッドThe Brigham and Women’s Hospital, Inc. |
Bmp阻害剤およびその使用方法
|
CN108997225A
(zh)
|
2013-03-14 |
2018-12-14 |
特雷罗药物股份有限公司 |
Jak2和alk2抑制剂及其使用方法
|
US20160022683A1
(en)
|
2013-03-14 |
2016-01-28 |
Pharmacyclics Llc |
Combinations of bruton's tyrosine kinase inhibitors and cyp3a4 inhibitors
|
JP6473133B2
(ja)
|
2013-03-15 |
2019-02-20 |
アラクセス ファーマ エルエルシー |
Krasg12cの共有結合性阻害剤
|
WO2014143659A1
(en)
|
2013-03-15 |
2014-09-18 |
Araxes Pharma Llc |
Irreversible covalent inhibitors of the gtpase k-ras g12c
|
EP2983670A4
(en)
|
2013-04-08 |
2017-03-08 |
Pharmacyclics LLC |
Ibrutinib combination therapy
|
JP6458018B2
(ja)
|
2013-07-02 |
2019-01-23 |
ファーマサイクリックス エルエルシー |
キナーゼ阻害剤としてのプリノン化合物
|
KR20160062103A
(ko)
|
2013-09-30 |
2016-06-01 |
파마싸이클릭스 엘엘씨 |
브루톤 티로신 키나제의 억제제
|
KR20160076519A
(ko)
|
2013-10-10 |
2016-06-30 |
아락세스 파마 엘엘씨 |
Kras g12c 억제제
|
JP6525236B2
(ja)
|
2014-09-01 |
2019-06-05 |
能美防災株式会社 |
減光式煙検知器
|
MX2017008430A
(es)
|
2014-12-23 |
2018-03-23 |
Cephalon Inc |
Métodos para preparar derivados de 2,4-diaminopirimidina bíclica fusionada.
|
WO2016146651A1
(en)
|
2015-03-16 |
2016-09-22 |
Oncodesign Sa |
Macrocyclic activin-like receptor kinase inhibitors
|
CN107531697A
(zh)
|
2015-04-16 |
2018-01-02 |
默克专利股份公司 |
3‑(1h‑苯并咪唑‑2‑基)‑1h‑吡啶‑2‑酮衍生物
|
JP6510075B2
(ja)
|
2015-05-18 |
2019-05-08 |
トレロ ファーマシューティカルズ, インコーポレイテッド |
バイオアベイラビリティが高いアルボシジブプロドラッグ
|
AU2017250302B2
(en)
|
2016-04-15 |
2021-01-21 |
Blueprint Medicines Corporation |
Inhibitors of activin receptor-like kinase
|
JP7076741B2
(ja)
|
2016-12-27 |
2022-05-30 |
国立研究開発法人理化学研究所 |
Bmpシグナル阻害化合物
|
AR112027A1
(es)
|
2017-06-15 |
2019-09-11 |
Biocryst Pharm Inc |
Inhibidores de alk 2 quinasa que contienen imidazol
|
US11013741B1
(en)
|
2018-04-05 |
2021-05-25 |
Sumitomo Dainippon Pharma Oncology, Inc. |
AXL kinase inhibitors and use of the same
|
WO2020023910A1
(en)
|
2018-07-26 |
2020-01-30 |
Tolero Pharmaceuticals, Inc. |
Methods for treating diseases associated with abnormal acvr1 expression and acvr1 inhibitors for use in the same
|